William J. Caragol, Chairman and CEO of PositiveID, called into SmallCapVoice.com to cover the exciting recent news for the Company. PositiveID Corporation (“PositiveID”) (PSID), an emerging growth company and developer of airborne bio-threat detection systems for America’s homeland defense industry as well as advanced technologies for rapid medical testing and diabetes management, recently announced it has entered into a license agreement and a teaming agreement with The Boeing Company (“Boeing”), including a license fee to PositiveID of $2.5 million.
PositiveID Corporation is an emerging growth company and developer of airborne bio-threat detection systems for America’s homeland defense industry as well as advanced technologies for rapid medical testing and diabetes management. Its wholly-owned subsidiary, Microfluidic Systems, is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment.